ACE Inhibitors, ARBs Cut Mortality in PD Patients
Peritoneal dialysis (PD) patients treated with ACE inhibitors or angiotensin receptor blockers (ARBs) have a lower mortality risk than PD patients not treated with these medications, researchers reported in Nephrology Dialysis Transplantation (online ahead of print).
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.